Introduction: Why Insulin Biosimilar Characterization Demands Analytical Precision Insulin biosimilar characterization is far more than a routine regulatory requirement. It […]
Insulin Biosimilar Characterization: Structural and Impurity Analysis Using LC-MS Read More »
Introduction: Why 2D NMR for Peptide Characterization Is an Essential Tool in Therapeutic Development When a therapeutic peptide progresses into
Introduction: When developing a next-generation injectable, implantable, or targeted therapy using poly(lactic-co-glycolic acid) (PLGA), one of the most consequential early
Introduction: The Bioanalytical Complexity of ADC Programs Bioanalysis for an Antibody-Drug Conjugate Program is far from a straightforward analytical exercise.
Case Study: Dual Analyte LC-MS/MS Bioanalysis for an Antibody-Drug Conjugate Program Read More »
Introduction: Nitrosamine Testing Inhalation Drug Products MDI DPI Nasal Spray has become a critical focus area for pharmaceutical manufacturers after
Nitrosamine Testing for Inhalation Drug Products: MDIs, DPIs, and Nasal Sprays Read More »
Introduction: Why AET Derivation Is the Defining Step in E&L Studies The Analytical Evaluation Threshold (AET) is the single most
Introduction: Why Peptide Biosimilar Characterization Using LC-MS Requires More Than Conventional Proteomics Peptide biosimilar characterization using LC-MS is far more
Peptide Biosimilar Characterization Using LC-MS: Challenges and Analytical Solutions Read More »
Introduction: Why Conventional Mutagenicity Models Are Inadequate for NDSRIs The regulatory complexity associated with N-Nitrosamine Drug Substance-Related Impurities (NDSRIs) extends
Introduction: Anti-Drug Antibody (ADA) Assay Development Services play a critical role in evaluating the immunogenicity of biologic therapies. As biologics
Introduction: Why CRO Selection Is a Regulatory Decision, Not Just a Scientific One When sponsors prepare regulated bioanalytical services for
Regulated Bioanalytical Services for NDA and BLA Submissions: What to Look for in a CRO Read More »
